We hypothesized that pentamidine curbs the ability of the cancer cells to destroy T cells by binding with PD-L1 expressed by humanized murine tumor cells, thereby allowing T cells to infiltrate the tumor and initiate an anti-tumor immune response. This evidence concerns the gene CD274 and cancer.